$3.31
-0.05(-1.49%)
Mkt Cap $418M
$0.64
$3.95
52-Week Range
At A Glance
1
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome.
2
Most recently: and the exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), (2026-02-26).
$418M
Market Cap
—
Revenue
-$59M
Net Income
Employees134
Fundamentals
How The Business Makes Money
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
Industry Biotechnology
Activity
Analyst View
Company Profile
CIK0001808805
ISINUS63909J1088
CUSIP63909J108
Phone206 333 2001
Address2701 Eastlake Avenue East, Seattle, WA, 98102, US
SEC EDGAR